Nitro-oleic acid attenuates OGD/R-triggered apoptosis in renal tubular cells via inhibition of bax mitochondrial translocation in a ppar-γ-dependent manner

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 1201-1218

  Nie, Huibin ^a   Xue, Xia ^b   Li, Jie ^c   Liu, Xiangchun ^a   Lv, Shasha ^a   Guan, Guangju ^a   Liu, Haiying ^a   Liu, Gang ^a   Liu, Shanshan ^a   Chen, Zhixin ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c Department of Otolaryngology   (China)

Author keywords

Apoptosis; Bax; Mitochondria; Nitro oleic Acid; OGD R

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; APOPTOSIS INDUCING FACTOR; CASPASE 3; CYTOCHROME C; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; NITRO OLEIC ACID; OLEIC ACID; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTECTIVE AGENT; PROTEIN BAX; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; GLYCOGEN SYNTHASE KINASE 3 BETA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETER; GENE TRANSLOCATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; REOXYGENATION; REPERFUSION INJURY; WESTERN BLOTTING; BIOSYNTHESIS; CELL HYPOXIA; DRUG EFFECTS; GENETICS; INJURIES; KIDNEY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANILIDES; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL HYPOXIA; CYTOCHROMES C; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KIDNEY; MITOCHONDRIA; OLEIC ACID; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84924674421     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000373944     Document Type: Article

References (56)

1. Friedman EA: Acute renal failure. N Engl J Med 1996;335:1321; author reply 1321-1322.
2. Eltzschig HK, Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 2011;17:1391-1401.
3. Yousefipour Z, Oyekan A, Newaz M: Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure. Pharmacol Ther 2010;125:436-445.
4. Bonegio R, Lieberthal W: Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 2002;11:301-308.
5. Wolfs TG, de Vries B, Walter SJ, Peutz-Kootstra CJ, van Heurn LW, Oosterhof GO, Buurman WA: Apoptotic cell death is initiated during normothermic ischemia in human kidneys. Am J Transplant 2005;5:68-75.
6. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumberg RS, Nagai R, Matsuhashi H: Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001;120:460-469.
7. Yasuda S, Kobayashi H, Iwasa M, Kawamura I, Sumi S, Narentuoya B, Yamaki T, Ushikoshi H, Nishigaki K, Nagashima K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S: Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction. Am J Physiol Heart Circ Physiol 2009;296:H1558-1565.
8. Fong WH, Tsai HD, Chen YC, Wu JS, Lin TN: Anti-apoptotic actions of PPAR-gamma against ischemic stroke. Mol Neurobiol 2010;41:180-186.
9. Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N: Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury. Transplantation 2007;84:207-213.
10. Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, dIschia M: Nitro-fatty acid formation and signaling. J Biol Chem 2008;283:15515-15519.
11. Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Baker PR, Batthyany C, Chacko BK, Feng X, Patel RP, Agarwal A, Freeman BA, Chen YE: Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J Biol Chem 2006;281:35686-35698.
12. Reddy AT, Lakshmi SP, Dornadula S, Pinni S, Rampa DR, Reddy RC: The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease. J Immunol 2013;191:2053-2063.
13. Ichikawa T, Zhang J, Chen K, Liu Y, Schopfer FJ, Baker PR, Freeman BA, Chen YE, Cui T: Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1. Endocrinology 2008;149:4086-4094.
14. Lies KE, Wright MM, Cole MP, Welty NE, Ware LB, Matthay MA, Schopfer FJ, Baker PR, Agarwal A, Freeman BA: Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway. Free Radic Biol Med 2009;46:866-875.
15. Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, Chumley P, lies KE, Freeman BA, Agarwal A: Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci USA 2006;103:4299-4304.
16. Khoo NK, Rudolph V, Cole MP, Golin-Bisello F, Schopfer FJ, Woodcock SR, Batthyany C, Freeman BA: Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids. Free Radic Biol Med 2010;48:230-239.
17. Kansanen E, Jyrkkanen HK, Volger OL, Leinonen H, Kivela AM, Hakkinen SK, Woodcock SR, Schopfer FJ, Horrevoets AJ, Yla-Herttuala S, Freeman BA, Levonen AL: Nrf2-dependent and-independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid. J Biol Chem 2009;284:33233-33241.
18. Schopfer FJ, Lin Y, Baker PR, Cui T, Garcia-Barrio M, Zhang J, Chen K, Chen YE, Freeman BA: Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci USA 2005;102:2340-2345.
19. Baker PR, Lin Y, Schopfer FJ, Woodcock SR, Groeger AL, Batthyany C, Sweeney S, Long MH, lies KE, Baker LM, Branchaud BP, Chen YE, Freeman BA: Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J Biol Chem 2005;280:42464-42475.
20. Schopfer FJ, Cole MP, Groeger AL, Chen CS, Khoo NK, Woodcock SR, Golin-Bisello F, Motanya UN, Li Y, Zhang J, Garcia-Barrio MT, Rudolph TK, Rudolph V, Bonacci G, Baker PR, Xu HE, Batthyany CI, Chen YE, Hallis TM, Freeman BA: Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. J Biol Chem 2010;285:12321-12333.
21. Reddy AT, Lakshmi SP, Reddy RC: The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice. PPAR Res 2012;2012:617063.
22. Borniquel S, Jansson EA, Cole MP, Freeman BA, Lundberg JO: Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease. Free Radic Biol Med 2010;48:499-505.
23. Rudolph V, Rudolph TK, Schopfer FJ, Bonacci G, Woodcock SR Cole MP, Baker PR, Ramani R, Freeman BA: Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res 2010;85:155-166.
24. Liu H, Jia Z, Soodvilai S, Guan G, Wang MH, Dong Z, Symons JD, Yang T: Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury. Am J Physiol Renal Physiol 2008;295:F942-949.
25. Modis K, Gero D, Nagy N, Szoleczky P, Toth ZD, Szabo C: Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis. Br J Pharmacol 2009;158:1565-1578.
26. Szoleczky P, Modis K, Nagy N, Dori Toth Z, DeWitt D, Szabo C, Gero D: Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources inLLC-PKl cells during hypoxia. Arch Biochem Biophys 2012;517:53-70.
27. Saenz-Morales D, Conde E, Escribese MM, Garcia-Martos M, Alegre L, Bianco-Sanchez I, Garcia-Bermejo ML: ERK1/2 mediates cytoskeleton and focal adhesion impairment in proximal epithelial cells after renal ischemia. Cell Physiol Biochem 2009;23:285-294.
28. Wu JS, Lin TN, Wu KK: Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J Cell Physiol 2009;220:58-71.
29. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA: Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004;24:9993-10002.
30. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD: Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002;111:331-342.
31. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-789.
32. Cross DA, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD: Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem 2001;77:94-102.
33. Wang H, Liu H, Jia Z, Olsen C, Litwin S, Guan G, Yang T: Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice. Am J Physiol Renal Physiol 2010;298:F754-762.
34. Liu S, Jia Z, Zhou L, Liu Y, Ling H, Zhou SF, Zhang A, Du Y, Guan G, Yang T: Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. Am J Physiol Renal Physiol 2013;305:F1533-1541.
35. Nadtochiy SM, Baker PR, Freeman BA, Brookes PS: Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc Res 2009;82:333-340.
36. Nadtochiy SM, Zhu Q, Urciuoli W, Rafikov R, Black SM, Brookes PS: Nitroalkenes confer acute cardioprotection via adenine nucleotide translocase 1. J Biol Chem 2012;287:3573-3580.
37. Rosen S, Heyman SN: Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models. Kidney Int 2001;60:1220-1224.
38. Shi Y, Melnikov VY, Schrier RW, Edelstein CL: Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol 2000;279:F509-517.
39. Daemen MA, van 'tVeer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999;104:541-549.
40. Tang X, Guo Y, Nakamura K, Huang H, Hamblin M, Chang L, Villacorta L, Yin K, Ouyang H, Zhang J: Nitroalkenes induce rat aortic smooth muscle cell apoptosis via activation of caspase-dependent pathways. Biochem Biophys Res Commun 2010;397:239-244.
41. Wang Z, Havasi A, Gall J, Bonegio R, Li Z, Mao H, Schwartz JH, Borkan SC: GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol 2010;21:284-294.
42. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99-163.
43. Hsu YT, Wolter KG, Youle RJ: Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 1997;94:3668-3672.
44. Ravagnan L, Roumier T, Kroemer G: Mitochondria, the killer organelles and their weapons. J Cell Physiol 2002;192:131-137.
45. Havasi A, Li Z, Wang Z, Martin JL, Botla V, Ruchalski K, Schwartz JH, Borkan SC: Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2008;283:12305-12313.
46. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL, Henson PM: Phosphorylation of Bax Serl84 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004;279:21085-21095.
47. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
48. van Bilsen M, van Nieuwenhoven FA: PPARs as therapeutic targets in cardiovascular disease. Expert Opin Ther Targets 2010;14:1029-1045.
49. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C: Rosiglitazone and 15-deoxy-Deltal2, 14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 2003;140:366-376.
50. Wada K, Nakajima A, Takahashi H, Yoneda M, Fujisawa N, Ohsawa E, Kadowaki T, Kubota N, Terauchi Y, Matsuhashi N, Saubermann LJ, Nakajima N, Blumberg RS: Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2004;287:G452-458.
51. Li Y, Zhang J, Schopfer FJ, Martynowski D, Garcia-Barrio MT, Kovach A, Suino-Powell K, Baker PR, Freeman BA, Chen YE, Xu HE: Molecular recognition of nitrated fatty acids by PPAR gamma. Nat Struct Mol Biol 2008;15:865-867.
52. Kilter H, Werner M, Roggia C, Reil JC, Schafers HJ, Kintscher U, Bohm M: The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation. Diabetes Obes Metab 2009;11:1060-1067.
53. Morrison A, Yan X, Tong C, Li J: Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. Am J Physiol Heart Circ Physiol 2011;301:H895-902.
54. Yi JH, Park SW, Brooks N, Lang BT, Vemuganti R: PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res 2008;1244:164-172.
55. Batthyany C, Schopfer FJ, Baker PR, Duran R, Baker LM, Huang Y, Cervenansky C, Branchaud BP, Freeman BA: Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J Biol Chem 2006;281:20450-20463.
56. Barford D, Jia Z, Tonks NK: Protein tyrosine phosphatases take off. Nat Struct Biol 1995;2:1043-1053.